Figure 6.

TGFBR2 downregulation weakened the promotion of miR-410-3p inhibition on cell progression in propofol-treated glioma cells. Glioma cells were transfected with anti-NC, anti-miR-410-3p, si-NC, or si-TGFBR2 and then exposed to 10 μg/mL of propofol for 24 h. (A, B) The expression of TGFBR2 in glioma cells was determined by Western blot assay. (C, D) Proliferation of glioma cells was evaluated by MTT assay. (E, F) Migration and invasion of glioma cells were evaluated by Transwell assay. * P<0.05.